Breaking News Instant updates and real-time market news.

SAGE

Sage Therapeutics

$179.90

0.71 (0.40%)

06:34
02/07/18
02/07
06:34
02/07/18
06:34

Sage Therapeutics receives FDA Breakthrough Therapy Designation for SAGE-217

Sage Therapeutics announced that the U.S. FDA granted Breakthrough Therapy designation to SAGE-217 for the treatment of major depressive disorder. This is the second Breakthrough Therapy designation granted to Sage since 2016.

  • 30

    May

SAGE Sage Therapeutics
$179.90

0.71 (0.40%)

12/08/17
NEED
12/08/17
NO CHANGE
Target $193
NEED
Buy
Sage Therapeutics price target raised to $193 from $100 at Needham
Needham analyst Danielle Brill raised her price target on Sage Therapeutics to $193 following positive Phase 2 results of SAGE-217 in major depressive disorder cases. Brill says that given the "clear and consistent benefit" of the treatment, she has "increased confidence that '217 may have utility in a broad spectrum of mood disorders". In addition to reaching "blockbuster status", the analyst contends that '217 raises the possibility of a near term M&A approach from big pharma.
12/08/17
RAJA
12/08/17
NO CHANGE
Target $206
RAJA
Strong Buy
Sage Therapeutics price target raised to $206 from $109 at Raymond James
Raymond James analyst Laura Chico raised Sage Therapeutics' price target to $206 following positive Phase 2 results of SAGE-217 in major depressive disorder cases. Chico raised her prior market share and probability of success assumptions, as well as adding credit in postpartum depression and thinks the update de-risks that program. The analyst has a Strong Buy rating on Sage shares.
12/08/17
BMOC
12/08/17
NO CHANGE
Target $203
BMOC
Outperform
Sage Therapeutics price target raised to $203 from $112 at BMO Capital
BMO Capital analyst Gary Nachman raised his price target on Sage Therapeutics to $203 and kept his Outperform rating after releasing Phase 2 SAGE-217 major depressive disorder data that "transforms the company". Nachman says he sees high probability of success for the treatment as it progresses to larger Phase 3 studies and calls it a "game changer" in the very large major depressive disorder / post-partum depression markets. The analyst also says the company remains an "attractive acquisition candidate".
01/31/18
BMOC
01/31/18
NO CHANGE
Target $203
BMOC
Outperform
Sage data support exploring sleep disorders, says BMO Capital
In a relatively small proof-of-concept study, SAGE-217 demonstrated a potential benefit in improving sleep, BMO Capital analyst Gary Nachman tells investors in a research note. These data support Sage Therapeutics exploring SAGE-217 for sleep disorders, the analyst adds. He believes validation for sleep disorders opens up the product to a "whole other large therapeutic area that could drive further upside." Nachman reiterates an Outperform rating on Sage with a $203 price target. The stock in morning trading is up 2.5% to $189.21.

TODAY'S FREE FLY STORIES

CYH

Community Health

$4.46

-0.18 (-3.88%)

15:55
06/21/18
06/21
15:55
06/21/18
15:55
Hot Stocks
Breaking Hot Stocks news story on Community Health »

S&P revises Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

AMZN

Amazon.com

$1,728.40

-21.19 (-1.21%)

15:53
06/21/18
06/21
15:53
06/21/18
15:53
Periodicals
Leak shows Amazon Prime Day to start on July 16, TechRadar says »

Amazon's annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$52.31

-1.15 (-2.15%)

15:50
06/21/18
06/21
15:50
06/21/18
15:50
Options
Intel implied volatility moves higher as shares slide »

Intel implied volatility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

VDMCY

Vodacom

$0.00

(0.00%)

15:49
06/21/18
06/21
15:49
06/21/18
15:49
Conference/Events
Vodacom management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

PCRX

Pacira

$35.40

-4.45 (-11.17%)

, HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

15:42
06/21/18
06/21
15:42
06/21/18
15:42
Recommendations
Pacira, Heron Therapeutics analyst commentary  »

Pacira's Exparel may…

PCRX

Pacira

$35.40

-4.45 (-11.17%)

HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

QQQ

Invesco QQQ Trust

$175.78

-1.47 (-0.83%)

15:40
06/21/18
06/21
15:40
06/21/18
15:40
Options
Contrarian flow in QQQ 1day calls »

Contrarian flow in QQQ…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMSEY

Samsonite International

$0.00

(0.00%)

15:40
06/21/18
06/21
15:40
06/21/18
15:40
Conference/Events
Samsonite International management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

SENS

Senseonics

$4.93

0.07 (1.44%)

15:37
06/21/18
06/21
15:37
06/21/18
15:37
Hot Stocks
Senseonics up 5% after reopening following FDA approval news »

Senseonics shares are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

WATT

Energous

$16.10

-0.61 (-3.65%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Options
Energous put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:35
06/21/18
06/21
15:35
06/21/18
15:35
Hot Stocks
Breaking Hot Stocks news story on Senseonics »

Senseonics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

LDOS

Leidos

$57.77

-0.57 (-0.98%)

15:29
06/21/18
06/21
15:29
06/21/18
15:29
Recommendations
Leidos analyst commentary  »

Leidos may have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

LDOS

Leidos

$57.75

-0.59 (-1.01%)

, HRS

Harris

$143.06

-2.18 (-1.50%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Periodicals
TSA terminates contract with Peraton, Washington Business Journal says »

The Transportation…

LDOS

Leidos

$57.75

-0.59 (-1.01%)

HRS

Harris

$143.06

-2.18 (-1.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

FOSL

Fossil

$31.65

2.43 (8.32%)

15:25
06/21/18
06/21
15:25
06/21/18
15:25
Options
Fossil call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

, SPX

S&P 500

$0.00

(0.00%)

15:22
06/21/18
06/21
15:22
06/21/18
15:22
Technical Analysis
Technical Take: S&P 500 at important technical juncture into the close »

Last week in a summary…

SPY

SPDR S&P 500 ETF Trust

$274.42

-1.58 (-0.57%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.58

0.08 (0.15%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Periodicals
Wells Fargo said to let go of 10 analysts to cut costs, Bloomberg reports »

Wells Fargo is said to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jul

  • 12

    Apr

  • 16

    Jul

  • 15

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
06/21/18
06/21
15:17
06/21/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
06/21/18
06/21
15:16
06/21/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SENS

Senseonics

$4.93

0.07 (1.44%)

15:15
06/21/18
06/21
15:15
06/21/18
15:15
Hot Stocks
Senseonics says FDA approves PMA to market Eversense CGM System »

Senseonics Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

15:15
06/21/18
06/21
15:15
06/21/18
15:15
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

SRE

Sempra Energy

$111.85

-0.68 (-0.60%)

15:12
06/21/18
06/21
15:12
06/21/18
15:12
Hot Stocks
CPUC rejects SGE&E, SoCalGas request to build new nat gas pipeline in San Diego »

The California Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$64.28

-0.59 (-0.91%)

15:10
06/21/18
06/21
15:10
06/21/18
15:10
Options
CSX sees increased put activity »

CSX sees increased put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 26

    Aug

MFG

Mizuho Financial Group

$3.37

-0.07 (-2.03%)

15:05
06/21/18
06/21
15:05
06/21/18
15:05
Conference/Events
Mizuho Financial Group management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

HRTX

Heron Therapeutics

$40.10

9.4 (30.62%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Recommendations
Heron Therapeutics analyst commentary  »

Heron Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

SGH

Smart Global

$40.24

-0.27 (-0.67%)

15:04
06/21/18
06/21
15:04
06/21/18
15:04
Options
SMART Global options imply 15.6% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jun

  • 07

    Jul

  • 09

    Jul

  • 10

    Jul

  • 12

    Jul

STMP

Stamps.com

$249.35

-30.95 (-11.04%)

15:02
06/21/18
06/21
15:02
06/21/18
15:02
Recommendations
Stamps.com analyst commentary  »

Any selloff in Stamps.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.